# Core A: Administrative Core

> **NIH NIH U19** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2024 · $4,640,499

## Abstract

PROJECT SUMMARY/ABSTRACT - Core A (Administrative Core), The University of Texas Medical
Branch at Galveston
The Administrative Core is responsible for the overall management and coordination of the Research and
Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Center:
“Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center” (PABVAX). It provides governance,
operational management, and financial oversight functions to facilitate the execution of the overall research plan
and goals, thereby enabling the Center to fulfill its mission to develop effective vaccine and antibody-based
countermeasures for select virus prototypes within the Paramyxoviridae and Bunyavirales. The Administrative
Core will provide an organizational and programmatic structure to promote research productivity and synergy
through scientific interactions. The Administrative Core will provide oversight in setting Center priorities, including
decision making processes involving the continual evaluation of research and translational product development
activities. Administrative Core personnel will ensure that the Center is compliant with issues involving the use
of vertebrate animals and human subjects and ensure that regulatory expertise is available for associated
translational activities. Management activities will also be expected to be routinely carried out with the guidance
of the Scientific Advisory Board, in collaboration with the appropriate NIAID program administrators, to facilitate
go and no-go project decisions. Teleconferencing and videoconferencing will be maximally utilized to facilitate
communication between the University of Texas Medical Branch, the lead institution for the Center, and all other
participating institutions and organizations.

## Key facts

- **NIH application ID:** 10862497
- **Project number:** 1U19AI181930-01
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** Thomas William Geisbert
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $4,640,499
- **Award type:** 1
- **Project period:** 2024-07-30 → 2027-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10862497

## Citation

> US National Institutes of Health, RePORTER application 10862497, Core A: Administrative Core (1U19AI181930-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10862497. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
